Octocog alfa, plasma/albumin-free method: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 6, 2006-06 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Octocog alfa, Plasma/Albumin-Free Method: A Viewpoint by Massimo Franchini

By Franchini Massimo  

Drugs, Vol. 65, Iss. 18, 2005-01 ,pp. : 2621-2622

Adis International

Access to resources Recommend Favorite

Octocog Alfa, Antihaemophilic Factor (Recombinant), Plasma/Albumin Free Method (Advate®): A Review of its Use in the Management of Patients with Haemophilia A

By Dhillon Sohita  

Drugs, Vol. 72, Iss. 7, 2012-05 ,pp. : 987-1007

Adis International

Access to resources Recommend Favorite

Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A: Comparison with B-Domain Deleted rFVIII, and Value of Potential Viral Transmission Reduction due to Plasma/Albumin-Free Status

By Sclar David A.   Evans Marc A.   Skaer Tracy L.   Robison Linda M.   Chung Karen C.   Poulios Nick S.  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite

Factor VIIIC/octocog alfa: Anaphylaxis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1144, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite